Skip to main content
. 2020 Sep 1;9(9):565. doi: 10.3390/antibiotics9090565

Table 3.

Subgroup analysis for comparisons of the prevalence of VRE across study regions.

Study Region Number of Studies Prevalence (%) 95% CI I2 (%) Q Heterogeneity Test
DF p
South-West 8 20.7 13.1–28.2 95.5 155.404 7 <0.001
North-Central 3 22.4 −3.6–48.3 97.81 91.227 2 <0.001
South-East 3 10.2 2.7–17.8 51.15 4.094 2 0.129
North-West 1 25.0 3.8–46.2 NA - - -
South-South 4 56.2 33.5–79.0 88.37 25.802 3 <0.001
Overall 19 25.3 19.8–30.8 96.26 480.667 18 <0.001